WeLeader Biomedical Co., Ltd. (TPEX:7713)
Taiwan
· Delayed Price · Currency is TWD 67.00
-0.50 (-0.74%)
Apr 29, 2026, 9:35 AM CST
WeLeader Biomedical Market Cap
WeLeader Biomedical has a market cap or net worth of 3.07 billion as of April 28, 2026. Its market cap has increased by 22.64% in one year.
Market Cap
3.07B
Enterprise Value
3.59B
Revenue
1.11B
Ranking
n/a
PE Ratio
14.92
Stock Price
67.00
Market Cap Chart
Since January 2, 2024, WeLeader Biomedical's market cap has decreased from 3.43B to 3.07B, a decrease of -10.51%. That is a compound annual growth rate of -4.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 3.07B | -8.04% |
| Dec 31, 2025 | 3.34B | 2.93% |
| Dec 31, 2024 | 3.24B | -5.45% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medimaging Integrated Solution | 2.70B |
| A Plus Biotechnology | 2.52B |
| Bonraybio | 4.07B |
| Applied BioCode | 2.25B |
| Dynamic Medical Technologies | 2.25B |
| Wellell | 2.24B |
| OK Biotech | 1.82B |
| Delta Asia International | 5.24B |